STAAR Surgical Reports Fourth Quarter and Full Year 2018 Results
MONROVIA, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the fourth quarter and full year ended December 28, 2018. Fourth Quarter 2018 Overview Net Sales of $31.2 Million Up 26% from the Prior Year Quarter ICL Sales Up 41% and Units Up 54% from the Prior Year Quarter Gross Margin at 73.7% of Sales from 69.9% of Sales in the Prior